Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
about
T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.Proteomics profiling of CLL versus healthy B-cells identifies putative therapeutic targets and a subtype-independent signature of spliceosome dysregulation.Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
P2860
Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@en
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@nl
type
label
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@en
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@nl
prefLabel
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@en
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@nl
P2093
P2860
P50
P356
P1476
Integrated Cellular and Plasma ...... nique and Systemic Signatures.
@en
P2093
Antigoni Manousopoulou
Kerry L Cox
Matthew J Carter
Melanie Dunscombe
Paul A Townsend
P2860
P304
P356
10.1074/MCP.M116.063511
P577
2017-01-04T00:00:00Z